Pseudoephedrine-Associated Arrhythmias and Cardiovascular Risks
Mechanism and Cardiovascular Effects
- Pseudoephedrine is an α-adrenergic agonist that acts as a systemic vasoconstrictor, producing measurable cardiovascular effects even at therapeutic doses, according to the Journal of Allergy and Clinical Immunology 1
- Increases heart rate by 2.83 beats/min (95% CI, 2.0-3.6) 2
- Increases systolic blood pressure by 0.99 mmHg (95% CI, 0.08-1.90) 2
- Can trigger palpitations, insomnia, and irritability as common side effects 1
High-Risk Patient Populations
- Pseudoephedrine must be used with caution in patients with angina pectoris or coronary artery disease 2
- Pseudoephedrine must be used with caution in patients with cerebrovascular disease 2
- Pseudoephedrine must be used with caution in patients with hypertension (controlled or uncontrolled) 3
- Pseudoephedrine must be used with caution in patients with hyperthyroidism 3
- Pseudoephedrine must be used with caution in young children and infants, who are at risk of agitated psychosis, ataxia, hallucinations, and death 1
Clinical Recommendations
- The American College of Cardiology recommends avoiding pseudoephedrine in patients with uncontrolled hypertension 3
- Topical nasal decongestants (oxymetazoline/Afrin) are preferred over oral pseudoephedrine due to minimal systemic absorption 2
- Limit topical use to ≤3 days to avoid rhinitis medicamentosa (rebound congestion) 3